drug
balsalazide disodium
Marketedupdated 3mo agoby Carnegie Pharmaceuticals LLC
Approvedcommunity read0 votes
indications
investigational
IBD (Crohn's + UC)
all catalysts(0)
nothing on the calendar yet
Trials studying balsalazide disodium
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 24, 2026
4 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (8)
- Jun 23, 2031method-of-use (U-1229)US 84972564.8y
- Feb 24, 2027patentUS 7452872*PED188d
- Feb 24, 2027patentUS 7625884*PED188d
- Aug 24, 2026method-of-use (U-1229)US 74528724d
- Aug 24, 2026method-of-use (U-141)US 74528724d
- Aug 24, 2026method-of-use (U-1229)US 76258844d
- Aug 24, 2026method-of-use (U-141)US 76258844d
- Aug 2, 2026method-of-use (U-1229)US 9192616
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 45m ago
Found something off?
comments(0)
5-min edit window · permanent after that